Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$370K Buy
1,342
+17
+1% +$4.8K 0.01% 354
2026
Q1
$353K Buy
1,325
+15
+1% +$4.15K 0.01% 342
2025
Q4
$361K Sell
1,310
-35
-3% -$9.81K 0.01% 350
2025
Q3
$388K Sell
1,345
-97
-7% -$28.7K 0.01% 345
2025
Q2
$477K Buy
1,442
+189
+15% +$60.9K 0.01% 273
2025
Q1
$412K Sell
1,253
-125
-9% -$37.7K 0.01% 256
2024
Q4
$381K Buy
1,378
+119
+9% +$37.9K 0.01% 282
2024
Q3
$436K Buy
1,259
+1
+0.1% +$344 0.01% 246
2024
Q2
$416K Buy
1,258
+84
+7% +$29K 0.01% 240
2024
Q1
$427K Hold
1,174
0.01% 241
2023
Q4
$351K Hold
1,174
0.01% 250
2023
Q3
$336K Buy
1,174
+15
+1% +$4.28K 0.01% 233
2023
Q2
$325K Buy
1,159
+5
+0.4% +$1.3K 0.01% 237
2023
Q1
$295K Sell
1,154
-27
-2% -$7.87K 0.01% 241
2022
Q4
$391K Sell
1,181
-1
-0.1% -$316 0.02% 223
2022
Q3
$328K Buy
1,182
+2
+0.2% +$563 0.02% 215
2022
Q2
$311K Buy
1,180
+17
+1% +$4.38K 0.02% 221
2022
Q1
$279K Hold
1,163
0.01% 244
2021
Q4
$267K Sell
1,163
-31
-3% -$6.59K 0.01% 254
2021
Q3
$239K Hold
1,194
0.01% 266
2021
Q2
$283K Sell
1,194
-81
-6% -$20.2K 0.01% 246
2021
Q1
$308K Sell
1,275
-66
-5% -$14.7K 0.01% 228
2020
Q4
$279K Sell
1,341
-60
-4% -$11.8K 0.01% 228
2020
Q3
$237K Hold
1,401
0.02% 225
2020
Q2
$263K Hold
1,401
0.02% 212
2020
Q1
$248K Sell
1,401
-95
-6% -$18.4K 0.02% 198
2019
Q4
$306K Buy
+1,496
New +$274K 0.02% 212

Other funds holding CI

Grimes & Company's CI Position: Q2 2026 in Review

Grimes & Company increased its Cigna (CI) stake by 1.3% in Q2 2026, buying an estimated $4.8K and bringing the position to 1,342 shares worth $370K. The position accounts for 0.01% of the portfolio, ranked #354.

Grimes & Company first reported a position in CI in Q4 2019 and has held it in 27 quarters since. The position peaked at $477K in Q2 2025. 476 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Grimes & Company held 1,342 shares of Cigna worth $370K as of Q2 2026.
  • Grimes & Company bought 17 Cigna shares in Q2 2026, an estimated $4.8K.
  • Cigna made up 0.01% of Grimes & Company's portfolio in Q2 2026, its #354 holding.
  • Grimes & Company first reported a position in Cigna in Q4 2019 and has held it in 27 quarters since.
  • Grimes & Company's Cigna position peaked at $477K in Q2 2025.
  • 476 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.